Page last updated: 2024-10-16

adenine and Prostatic Neoplasms, Castration-Resistant

adenine has been researched along with Prostatic Neoplasms, Castration-Resistant in 3 studies

Prostatic Neoplasms, Castration-Resistant: Tumors or cancer of the PROSTATE which can grow in the presence of low or residual amount of androgen hormones such as TESTOSTERONE.

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's3 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Mortezavi, A1
Salemi, S1
Kranzbühler, B1
Gross, O1
Sulser, T1
Simon, HU1
Eberli, D1
Chen, S1
Cai, C1
Sowalsky, AG1
Ye, H1
Ma, F1
Yuan, X1
Simon, NI1
Gray, NS1
Balk, SP1
Ma, X1
Zou, L1
Li, X1
Chen, Z1
Lin, Z1
Wu, X1

Other Studies

3 other studies available for adenine and Prostatic Neoplasms, Castration-Resistant

ArticleYear
Inhibition of autophagy significantly increases the antitumor effect of Abiraterone in prostate cancer.
    World journal of urology, 2019, Volume: 37, Issue:2

    Topics: Abiraterone Acetate; Adenine; Antineoplastic Agents; Apoptosis; Autophagy; Autophagy-Related Protein

2019
BMX-Mediated Regulation of Multiple Tyrosine Kinases Contributes to Castration Resistance in Prostate Cancer.
    Cancer research, 2018, 09-15, Volume: 78, Issue:18

    Topics: Adenine; Amino Acid Motifs; Androgen Antagonists; Androgens; Animals; Antibodies; Cell Line, Tumor;

2018
Inhibition of Autophagy Improves the Efficacy of Abiraterone for the Treatment of Prostate Cancer.
    Cancer biotherapy & radiopharmaceuticals, 2019, Volume: 34, Issue:3

    Topics: Adenine; Androstenes; Antineoplastic Combined Chemotherapy Protocols; Autophagy; Cell Line, Tumor; D

2019